Tumor Ablation Market Trends, Size, Share, Analysis, 2024-2032 | IMARC Group


(MENAFN- IMARC Group)
Tumor Ablation Market Trends, Size, Share, Analysis, 2024-2032 | IMARC Group Image

According to the latest report by IMARC Group, titled“ Tumor Ablation Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032 ”, offers a comprehensive analysis of the industry, which comprises insights on the global tumor ablation market. The report also includes competitor and regional analysis, and contemporary advancements in the market.

How Big is the Global Tumor Ablation Market:

The global tumor ablation market size reached US$ 1,200 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 3,100 Million by 2032, exhibiting a growth rate (CAGR) of 10.8% during 2024-2032.

Market Overview:

Tumor ablation is a minimally invasive surgical method used to treat solid cancers. It involves the direct application of chemical or thermal therapies to a tumor to achieve necrosis or cell death, within the targeted tissue. The primary goal is to destroy cancer cells without removing them, minimizing damage to surrounding healthy tissue and reducing the procedure's overall invasiveness compared to traditional surgery. This technique is commonly applied in the treatment of tumors in the liver, kidney, lung, and bone, among other areas. It's particularly beneficial for patients who may not be suitable candidates for conventional surgery due to the location of the tumor, underlying health conditions, or when the tumor is in its early stages and localized.

Request Free Sample Report: https://www.imarcgroup.com/tumor-ablation-market/requestsample

Global Tumor Ablation Market Trends:

The growing preference for minimally invasive therapies is driving the global market. Tumor ablation, a procedure used to destroy cancer cells with heat, cold, or other modalities, is becoming a favored option due to its advantages in terms of reduced recovery times, lower complication rates, and its effectiveness in targeting tumors with precision.

Moreover, innovations in ablation technology, such as improved imaging guidance, enhanced energy delivery systems, and the development of new modalities, such as microwave and irreversible electroporation, have increased the efficacy, safety, and applicability of tumor ablation. The rising demand for personalized and targeted cancer treatments is also propelling the tumor ablation market. As medical science advances, there is a clearer understanding that a one-size-fits-all approach is not effective for all cancer patients.

By the IMARC Group, Some of the Top Competitive Landscape Operating in the Global Tumor Ablation Industry are Given Below:

  • Medtronic
  • AngioDynamics Inc.
  • HealthTronics Inc.
  • NeuWave Medical
  • INTIO Inc.
  • Galil Medical Ltd.
  • Boston Scientific
  • Sonacare Medical
  • EDAP TMS S.A.
  • ERBE Elektromedizin GmbH
  • IceCure Medical Ltd.
  • MISONIX Inc
  • Endocare Inc.
  • CooperSurgical Inc.
  • B V M Meditech Pvt


Key Market Segmentation:

Breakup by Technology:

  • Radiofrequency (RF) Ablation
  • Microwave Ablation
  • Cryoablation
  • Others


Breakup by Mode of Treatment:

  • Percutaneous Ablation
  • Laparoscopic Ablation
  • Surgical Ablation


Breakup by Mode of Application:

  • Liver Cancer
  • Lung Cancer
  • Kidney Cancer
  • Bone Metastasis
  • Others


Breakup by End-User:

  • Hospitals
  • Cancer Specialty Clinics
  • Others


Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)


Key highlights of the Report:

  • Market Performance (2018-2023)
  • Market Outlook ( 2024-2032 )
  • COVID-19 Impact on the Market
  • Porter's Five Forces Analysis
  • Historical, Current and Future Market Trends
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Structure of the Market
  • Value Chain Analysis
  • Comprehensive Mapping of the Competitive Landscape


Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Contact US

IMARC Group


134 N 4th St. Brooklyn, NY 11249, USA
Email:
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800

MENAFN20032024004122016232ID1108000184


IMARC Group

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.